Treating Alzheimer’s Disease with Lifestyle Changes

πŸ₯
Clinical Trial β€” Recruiting Now

πŸ”¬ Active Clinical Trial: NCT07711639 | Status: RECRUITING | Phase: NA

View full trial details on ClinicalTrials.gov β†’

Taiwan Trial Tests Reflexology and Nerve Stimulation for Tinnitus Relief

An estimated 12-30% of adults experience tinnitus, that persistent perception of sound like ringing or buzzing when no external source exists. For many, it comes with anxiety, poor sleep, and physiological stress. Drugs often fail to provide sufficient relief. A new clinical trial at Hualien Tzu Chi Hospital is directly comparing two specific non-drug methods: targeted foot reflexology and transcutaneous auricular vagus nerve stimulation. This research could identify practical, side-effect-free options for managing the condition.

Key Takeaways

  • This trial will test if foot reflexology and ear-based vagus nerve stimulation can reduce tinnitus severity in 180 adults.
  • Researchers will measure changes in psychological distress, sleep quality, and stress hormones like cortisol.
  • The study design includes sham treatments to determine if the benefits are specific to the techniques used.
  • Eligible participants must have normal hearing thresholds and tinnitus as their primary complaint.
  • Results could provide evidence for integrating these non-pharmacological approaches into standard tinnitus care.

A Three-Arm, Sham-Controlled Design

The “FR-taVNS Tinnitus Tria” is a randomized, single-blind study led by investigators in Taiwan. It plans to enroll 180 participants and assign them to one of three arms: a foot reflexology (FR) group, a transcutaneous auricular vagus nerve stimulation (ta-VNS) group, or a usual-care control group. A critical feature is that both the FR and ta-VNS groups are further split. Half receive the real intervention, while half receive a sham version designed to feel similar but lack the specific therapeutic action. This allows the team to separate actual treatment effects from placebo responses.

Participants in the active foot reflexology group receive a 20-minute session once a week for four weeks. The protocol has three phases: relaxation, a phase targeting inner-ear and autonomic regulation points, and a final circulation phase. The sham version uses only light, non-specific touch. The active ta-VNS group also attends weekly 20-minute sessions for a month. A device delivers mild electrical stimulation to specific points on the left earβ€”the tragus, cymba conchae, and cavum conchae. The sham stimulation targets the left earlobe at a very low current. All participants in these two arms also perform daily self-administered auricular acupressure using magnetic beads.

The Science Behind Targeting the Ear and the Foot

The trial is built on the connection between tinnitus and the autonomic nervous system, which regulates stress, heart rate, and relaxation. Tinnitus distress is frequently linked to autonomic dysregulation. Transcutaneous auricular vagus nerve stimulation applies gentle electrical pulses to the outer ear, where branches of the vagus nerve are accessible. Stimulating this nerve is thought to influence brain networks involved in sound processing and emotional response, potentially calming the neural hyperactivity linked to tinnitus.

Foot reflexology is based on the principle that specific areas on the foot correspond to other body systems. The trial’s protocol includes stimulating zones believed to correlate with the inner ear and autonomic function. While the mechanisms are distinct from ta-VNS, the intended outcome is similar: to reduce the body’s stress response and, by extension, the perceived burden of tinnitus. The study will track objective autonomic indicators like heart rate variability and levels of the stress hormone salivary cortisol, alongside patient-reported questionnaires.

Who Can Participate and How Progress Is Tracked

The research team is looking for adults aged 18 to 75 whose main health complaint is tinnitus. A key inclusion criterion is relatively normal hearing, with pure-tone thresholds at or better than 25 dB HL at several test frequencies. This helps ensure the tinnitus is not primarily driven by significant hearing loss. The study excludes people with objective tinnitus (sound audible to an examiner), certain ear pathologies, open wounds on the foot or ear, diabetes with poorly controlled blood sugar, or implanted electronic devices like pacemakers.

Outcomes are measured four times: at baseline, week 2, week 4, and at a follow-up in week 8. Researchers will use the Tinnitus Handicap Inventory, along with scales for anxiety, depression, and sleep quality. The physiological data from heart rate monitors and saliva samples will provide a complementary picture to the subjective reports. Statisticians will analyze the results using generalized estimating equation models to see how changes evolve over time across the different groups.

Potential Impact on Future Tinnitus Management

As of now, the trial is actively recruiting its target of 180 participants. Positive results from this study would offer something valuable: clear protocols for non-invasive treatments that patients could receive in a clinic or, potentially, use at home with proper guidance. If foot reflexology or ta-VNS show specific benefits over sham treatments, it would strengthen the argument for their inclusion in integrative treatment plans. The focus on autonomic nervous system markers could also deepen the understanding of why these methods work, moving beyond subjective reports to measurable biological changes.

For patients, the ultimate promise is more choice. With pharmacological options limited, evidence-backed alternatives that address both the perceptual and distress components of tinnitus could significantly improve quality of life. The findings from this trial, expected after its completion and analysis, will contribute concrete data to a field that urgently needs effective and accessible interventions.

This article is for informational purposes only. Consult a qualified professional for personalised advice.


Source:
FR-taVNS Tinnitus Tria (ClinicalTrials.gov: NCT07711639)

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚑ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news β€” delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

Similar Posts